Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

NCT01067417 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

83

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

Medical Research Council

Collaborators

[object Object]